TSHA · Taysha Gene Therapies, Inc. · Investor Relations
$4.63
-0.11 (-2.32%)
At close · Oct 2
Return incl. dividend (before tax)
Market Cap
$1.52B
Shares
325.83M
Volume · Oct 2
3.44M
Avg daily vol (3M)
3.16M
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-08-11 | Taysha Gene Therapies Second Quarter 2026 Financial Results Conference Call | Earnings call |
| 2026-06-22 | TSHA-102 Rett Syndrome Program Update Conference Call | Conference |
| 2026-06-22 | Earnings conference call (announced in 8-K) | Earnings call |
| 2026-05-06 | Taysha Gene Therapies First Quarter 2026 Financial Results Conference Call | Earnings call |
| 2026-03-19 | Taysha Gene Therapies Full-Year 2025 Financial Results Conference Call | Earnings call |
| 2025-11-04 | Taysha Gene Therapies Third Quarter 2025 Financial Results Conference Call | Earnings call |
| 2025-08-12 | Taysha Gene Therapies Second Quarter 2025 Financial Results Conference Call | Earnings call |
Source: https://ir.tayshagtx.com/